PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50122P00014Purpose of THIS purchase ORDER IS — Orasure Technologies, Inc

Orasure Technologies, Inc holds $6.7M across 45 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jun 16, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Orasure Technologies, Inc

Recipient

Jun 16, 2027

PoP end

$1M

Obligated

$3.4M

Potential

325413

NAICS

6550

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Orasure Technologies, Inc — $90

Contract facts

NONE

Contract number75A50122P00014

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentOrasure Technologies, Inc

CAGE0PNX6

UEIY79RWFLHWDM6

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Place of performanceBETHLEHEM PA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitation75A50122Q00017

PoP startJun 22, 2022

PoP end (current)Jun 16, 2027

PoP end (w/ options)Jun 21, 2027

Obligated$1M

Current value$1.1M

Potential value$3.4M

THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS. is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Orasure Technologies, Inc. Estimated value $3.4M ($1M obligated). Current period of performance ends Jun 16, 2027 (potential Jun 21, 2027). Last award drew 1 bidder. Place of performance: BETHLEHEM PA. Related solicitation 75A50122Q00017.

THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS.

Recompete timing

Public

● Expiring in 299 days

Current PoP ends Jun 16, 2027 (299 days remaining). Agencies typically plan 12–18 months ahead — at 9.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Orasure Technologies, Inc — $6.7M obligated across 45 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$6.7M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

75A50122C00079

THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A SECOND-GENERATION ASSAY FOR THE ORAQUICK EB…

$15.5M

Jun 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50122P00014?

75A50122P00014 (Purpose of THIS purchase ORDER IS) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $3.4M, currently held by Orasure Technologies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50122P00014?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50122P00014 to Orasure Technologies, Inc (potential $3.4M).

Who is the incumbent on 75A50122P00014?

Orasure Technologies, Inc is the incumbent with $6.7M across 45 related awards in SCOUT’s public footprint. The current period of performance ends Jun 16, 2027.

When does Orasure Technologies, Inc’s 75A50122P00014 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 16, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Jul 1, 2026